225 related articles for article (PubMed ID: 7753843)
1. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.
Singh RK; Gutman M; Bucana CD; Sanchez R; Llansa N; Fidler IJ
Proc Natl Acad Sci U S A; 1995 May; 92(10):4562-6. PubMed ID: 7753843
[TBL] [Abstract][Full Text] [Related]
2. Cell density-dependent regulation of basic fibroblast growth factor expression in human renal cell carcinoma cells.
Singh RK; Llansa N; Bucana CD; Sanchez R; Koura A; Fidler IJ
Cell Growth Differ; 1996 Mar; 7(3):397-404. PubMed ID: 8838869
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.
Dinney CP; Bielenberg DR; Perrotte P; Reich R; Eve BY; Bucana CD; Fidler IJ
Cancer Res; 1998 Feb; 58(4):808-14. PubMed ID: 9485039
[TBL] [Abstract][Full Text] [Related]
4. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
5. Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-beta.
Jiang H; Lin JJ; Tao J; Fisher PB
Oncogene; 1997 Jan; 14(4):473-80. PubMed ID: 9053844
[TBL] [Abstract][Full Text] [Related]
6. Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer.
Riedel F; Götte K; Bergler W; Rojas W; Hörmann K
Head Neck; 2000 Mar; 22(2):183-9. PubMed ID: 10679908
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha-induced inhibition of B16 melanoma cell proliferation: interference with the bFGF autocrine growth circuit.
Torcia M; Lucibello M; De Chiara G; Labardi D; Nencioni L; Bonini P; Garaci E; Cozzolino F
Biochem Biophys Res Commun; 1999 Sep; 262(3):838-44. PubMed ID: 10471412
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.
Slaton JW; Perrotte P; Inoue K; Dinney CP; Fidler IJ
Clin Cancer Res; 1999 Oct; 5(10):2726-34. PubMed ID: 10537335
[TBL] [Abstract][Full Text] [Related]
9. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
10. Induction of growth suppression and modification of gene expression in multi-drug-resistant human glioblastoma multiforme cells by recombinant human fibroblast and immune interferon.
Moulton TA; Jiang H; Guarini L; Fetell MR; Fisher PB
Int J Cancer; 1992 May; 51(3):373-8. PubMed ID: 1317362
[TBL] [Abstract][Full Text] [Related]
11. Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha.
Ozawa S; Shinohara H; Kanayama HO; Bruns CJ; Bucana CD; Ellis LM; Davis DW; Fidler IJ
Neoplasia; 2001; 3(2):154-64. PubMed ID: 11420751
[TBL] [Abstract][Full Text] [Related]
12. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide.
Xie K; Bielenberg D; Huang S; Xu L; Salas T; Juang SH; Dong Z; Fidler IJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2283-94. PubMed ID: 9815626
[TBL] [Abstract][Full Text] [Related]
13. Isolation of human colon carcinoma cells for resistance to a single interferon associated with cross-resistance to multiple recombinant interferons: alpha, beta, and gamma.
Morikawa K; Morikawa R; Killion JJ; Fan D; Fidler IJ
J Natl Cancer Inst; 1990 Mar; 82(6):517-22. PubMed ID: 2138228
[TBL] [Abstract][Full Text] [Related]
14. Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells.
Booy S; van Eijck CH; Dogan F; van Koetsveld PM; Hofland LJ
J Cell Mol Med; 2014 Mar; 18(3):492-502. PubMed ID: 24460759
[TBL] [Abstract][Full Text] [Related]
15. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
[TBL] [Abstract][Full Text] [Related]
16. Synergistic anti-tumor effect of 13-cRA and IFN-alpha/beta in mouse renal cell carcinoma.
Taguchi I; Hara I; Gohji K; Arakawa S; Kamidono S
Int J Oncol; 1998 Jul; 13(1):145-9. PubMed ID: 9625816
[TBL] [Abstract][Full Text] [Related]
17. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells.
Matin SF; Rackley RR; Sadhukhan PC; Kim MS; Novick AC; Bandyopadhyay SK
Cancer Res; 2001 Mar; 61(5):2261-6. PubMed ID: 11280796
[TBL] [Abstract][Full Text] [Related]
18. Thrombopoietin production in human hepatic cell cultures (HepG2) is resistant to IFN-alpha, IFN-beta, and IFN-gamma treatment.
Wolber EM; Haase B; Jelkmann W
J Interferon Cytokine Res; 2002 Dec; 22(12):1185-9. PubMed ID: 12581491
[TBL] [Abstract][Full Text] [Related]
19. The effect of alpha and gamma interferon on cell growth and histocompatibility antigen expression by human renal carcinoma cells in vitro.
Angus R; Collins CM; Symes MO
Eur J Cancer; 1993; 29A(13):1879-85. PubMed ID: 8260246
[TBL] [Abstract][Full Text] [Related]
20. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
